Acturum Life Science AB
Records under this name other than patents Acturum Life Science AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Acturum Life Science AB
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,947,693 | 5,7-Disubstituted Thiazolo[4,5-d]pyrimidines as Chemokine Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 8,168,668 | Compounds Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,618,993 | Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 7,960,395 | 5,7-Disubstituted Thiazolo[4,5-d]pyrimidines for the Selective Inhibition of Chemokine Receptors Formerly held In force · High confidence | In force | High confidence | |
| US 7,842,803 | Nicotinic Acetylcholine Receptor Ligands 101 Formerly held In force · High confidence | In force | High confidence | |
| US 8,859,534 | 2-Carboxamide-7-Piperazinyl-Benzofuran Derivatives Formerly held Lapsed on the fee record Ended Oct 14, 2026 · High confidence | Lapsed on the fee record | Ended Oct 14, 2026 | High confidence |
| US 8,859,556 | TRPA1 Receptor Antagonist Formerly held Lapsed on the fee record Ended Oct 14, 2026 · High confidence | Lapsed on the fee record | Ended Oct 14, 2026 | High confidence |
| US 9,440,992 | 5,7-disubstituted thiazolo[4,5-D]pyrimidines as chemokine inhibitors Formerly held Term ended Term ended Aug 23, 2026 · USPTO record | Term ended | Term ended Aug 23, 2026 | USPTO record |
| US 9,718,805 | Triazole compounds and their use as gamma secretase modulators Lapsed on the fee record Ended Aug 1, 2025 · USPTO record | Lapsed on the fee record | Ended Aug 1, 2025 | USPTO record |
| US 9,611,254 | Triazole compounds and their use as gamma secretase modulators Formerly held Lapsed on the fee record Ended Apr 4, 2025 · USPTO record | Lapsed on the fee record | Ended Apr 4, 2025 | USPTO record |